Bleakley Financial Group’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,277
| Closed | -$42.7K | – | 1056 |
|
|
2024
Q2 | $42.7K | Buy |
3,277
+343
| +12% | +$4.46K | ﹤0.01% | 983 |
|
|
2024
Q1 | $66.5K | Buy |
2,934
+405
| +16% | +$9.17K | ﹤0.01% | 951 |
|
|
2023
Q4 | $32.8K | Buy |
+2,529
| New | +$32.8K | ﹤0.01% | 935 |
|
|
2023
Q3 | – | Sell |
-1,064
| Closed | -$28.6K | – | 924 |
|
|
2023
Q2 | $28.6K | Buy |
+1,064
| New | +$28.6K | ﹤0.01% | 910 |
|